SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-12-010321
Filing Date
2012-11-09
Accepted
2012-11-09 14:54:44
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2211708z10-q.htm 10-Q 544847
2 EX-31.1 a2211708zex-31_1.htm EX-31.1 8419
3 EX-31.2 a2211708zex-31_2.htm EX-31.2 8414
4 EX-32.1 a2211708zex-32_1.htm EX-32.1 9065
  Complete submission text file 0001047469-12-010321.txt   4779361

Data Files

Seq Description Document Type Size
5 EX-101.INS astx-20120930.xml EX-101.INS 561538
6 EX-101.SCH astx-20120930.xsd EX-101.SCH 38196
7 EX-101.CAL astx-20120930_cal.xml EX-101.CAL 61912
8 EX-101.DEF astx-20120930_def.xml EX-101.DEF 264673
9 EX-101.LAB astx-20120930_lab.xml EX-101.LAB 701417
10 EX-101.PRE astx-20120930_pre.xml EX-101.PRE 334243
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
Astex Pharmaceuticals, Inc (Filer) CIK: 0000919722 (see all company filings)

IRS No.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27628 | Film No.: 121193206
SIC: 2834 Pharmaceutical Preparations